Light-activated, drug-carrying liposomes show potential for minimally invasive glaucoma treatments

More than 4 million people in the U.S. have glaucoma, a group of eye diseases that can damage the optic nerve and lead to vision loss. It's the second-leading cause of blindness worldwide and there's currently no cure, but there's a way to help prevent vision loss through early detection and treatment.